The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 200.00
Bid: 200.00
Ask: 205.00
Change: -2.00 (-0.99%)
Spread: 5.00 (2.50%)
Open: 203.00
High: 203.00
Low: 200.00
Prev. Close: 202.00
JHD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

30 Mar 2009 07:00

RNS Number : 6608P
James Halstead PLC
30 March 2009
 



30 March 2009

JAMES HALSTEAD PLC

INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2008

Key Figures

James Halstead plc, manufacturer and international distributor of commercial floor coverings reports:

Turnover increased to a record £86.7 million - an increase of 10.4%

Operating profit increased to a record £15.1 million - an increase of 19.7%

Pre-tax profit increased to a record £15.4 million - an increase of 17.5%

Basic earnings per ordinary 5p share increased to a record 20.8p - an increase of 19.5%

Proposed interim dividend increased to a record 7.25 p - an increase of 16%

Nil net gearing

Chairman, Mr Geoffrey Halstead, commenting said:

"We have yet again achieved record results in very challenging market conditions. Our cash generation, market penetration and productivity have all moved forward. Many economies at the moment are in a difficult position but our conservative strategy of building our businesses solidly should allow us to weather these storms and this gives us the confidence to raise the interim dividend 16%". 

Enquiries:

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Telephone: 0161 767 2500

Nick Lyon - Hudson Sandler 

Telephone : 020 7796 4133

CHAIRMAN'S STATEMENT

I am pleased to report, once again, a record set of interim results. Whilst the economic backdrop has been challenging we have charted a successful course in the first six months of the trading year.

Trading

The first half year trading was very solid with record turnover of £86.65 million (2007: £78.45 million) representing an increase of 10.4. The majority of the sales growth was derived from our flooring activities though I would note Phoenix Distribution (our motorcycle accessories subsidiary) increased sales by 4% in difficult retail conditions.

Turnover growth was consistent in both UK and overseas markets, both achieving double digit growth with our international sales continuing to be in excess of UK sales.

Projects as diverse as Bombadier's Regina Trains in Sweden; the Cooking School in Halifax and the Mozzart Betting Hall in Serbia have continued to broaden our customer base for products traditionally sold into our core hospital and education markets. We are seeing increasing interest from specifiers and architects as a result of the high quality of our designs in high profile installations such as these.

Gross margins improved as raw material and energy costs softened in the second quarter. However, this was offset to an extent by the increased cost of factored products and some raw materials and consumables caused by adverse exchange rates. Overall the effect was marginally positive.

The profit before tax at £15.37 million (2007: £13.08 million) is another record performance and is a 17.5% increase on the comparative period. Finance income has fallen as a result of declines in interest rates. Cash inflow from operations was very positive increasing by 18.8% to £16.82 million (2007: £14.15 million).

Earnings per Share and Interim Dividend

Our basic earnings per share have increased to a record 20.8p (2007 : 17.4p) an uplift of 19.5% and having regard to these results and our strong cash balances the Board propose to pay an interim dividend of 7.25p (2007 : 6.25p) representing a 16% increase on last year and yet another record.

Outlook 

The half year result is encouraging. Looking forward, we have range changes and updates taking place in the second half and we continue to focus on productivity. Sterling weakness will, on balance, be a positive with our export performance more than compensating for higher cost of imported items. In addition, we are seeing reduced energy prices and this cost area is being targeted for efficiency improvement. These factors give us confidence for the coming months. However what cannot be ignored, is the general decline in global trade and widespread recessionary worries, which to date we have not experienced in terms of trading in our market sector, except for some smaller territories.

With talk of an economic "Pearl Harbour" we must remain alert to potential problems, whether they are deferred spending or credit risks. I am confident we have the management skills, products and reputation to strengthen market share in these difficult times in key territories.

 Whilst projects such as the Nevis Alexandra Hospital in Barbados, the Dubai Rugby Seven Stadium and VDL buses for Israel augment our breadth of expansion, there are significant projects such as Manchester and Birmingham schools closer to home that are targeted to underpin our second half budgets. Indeed, in the area of healthcare we have even managed to supply flooring to the BBC's "Casualty 1909", a new drama series.

The second half will be a hard challenge but we face it from a position of strength.

Geoffrey Halstead

Chairman

30 March 2009

  Consolidated Income Statement

for the half-year ended 31 December 2008

Half-year 

ended

31.12.08

£'000

Half-year 

ended 

31.12.07 

£'000 

Year 

ended

30.06.08

£'000

Revenue

86,650

78,453 

158,740 

Operating profit

15,052

12,579 

29,088 

Finance income

316

500 

769 

Profit before income tax

15,368

13,079 

29,857 

Income tax expense

(4,668)

(4,208)

(9,502)

Profit for the period

10,700

8,871 

20,355 

Earnings per ordinary share of 5p :

-basic

20.8p

17.4p

39.7p

-diluted

20.7p

17.2p

39.5p

All the above figures relate to continuing operations.

Details of dividends paid and proposed are given in note 3.

  Consolidated Balance Sheet

as at 31 December 2008

Half-year

ended

31.12.08

£'000

Half-year

ended

31.12.07

£'000

Year

ended

30.06.08

£'000

Non current assets

Property, plant and equipment

22,804

19,905

19,671

Intangible assets

3,232

3,232

3,232

Deferred tax assets

5,832

3,850

5,737

31,868

26,987

28,640

Current assets

Inventories

33,121

24,884

30,641

Trade and other receivables

25,835

24,045

23,034

Derivative financial instruments

741

59

149

Cash and cash equivalents

31,764

25,922

29,521

91,461

74,910

83,345

Current liabilities

53,722

50,104

48,631

Net current assets

37,739

24,806

34,714

Non-current liabilities

Retirement benefit obligations

12,227

7,158

12,505

Deferred tax liabilities

992

1,063

992

Other payables

594

662

550

13,813

8,883

14,047

Net Assets

55,794

42,910

49,307

Equity

Equity share capital

2,574

2,556

2,574

Equity share capital (B shares)

160

160

160

2,734

2,716

2,734

Share premium account

1,738

824

1,708

Retained earnings

39,941

34,883

36,455

Other reserves

11,381

4,487

8,410

Total equity attributable to shareholders of the parent

55,794

42,910

49,307

  Consolidated Cash Flow Statement

for the half-year ended 31 December 2008

Half-year

ended

31.12.08

£'000

Half-year

ended

31.12.07

£'000

Year

ended

30.06.08

£'000

Cash inflow from operations

16,818 

14,151 

27,298 

Interest received

606 

624 

1,261 

Interest paid

(94)

(120)

(243)

Taxation paid

(5,410)

(3,428)

(8,081)

Cash inflow from operating activities

11,920 

11,227 

20,235 

Purchase of property, plant and equipment

(3,015)

(2,702)

(3,370)

Proceeds from disposal of property, plant and equipment

73 

117 

205 

Cash outflow from investing activities

(2,942)

(2,585)

(3,165)

Equity dividends paid

(7,465)

(5,751)

(8,946)

Shares issued

30 

22 

924 

Interest paid

(6)

(6)

(117)

Repayment of debt

- 

- 

(2,653)

Cash outflow from financing activities

(7,441)

(5,735)

(10,792)

Net increase in cash and cash equivalents

1,537 

2,907 

6,278 

Effect of exchange differences 

706 

259 

487 

Cash and cash equivalents at start of period

29,521 

22,756 

22,756 

Cash and cash equivalents at end of period

31,764 

25,922 

29,521 

  Consolidated Statement of Recognised Income and Expense

for the half-year ended 31 December 2008

Half-year

ended

31.12.08

£'000 

Half-year

ended

31.12.07

£'000

Year

ended

30.06.08

£'000

Foreign currency translation differences

3,286 

827 

2,053 

Actuarial gain/(loss) on the pension scheme

251 

(537)

(4,683)

Fair value movements on hedged items

(315)

(213)

(169)

Net income/(expense) recognised directly in equity

3,222 

77 

(2,799)

Profit for the year

10,700 

8,871 

20,355 

Total recognised income for the period

13,922 

8,948 

17,556 

Attributable to :

Equity holders of the company

13,922 

8,948 

17,556 

  Notes to the Interim Results

for the half-year ended 31 December 2008

1.

Basis of preparation

The interim financial statements are unaudited and do not constitute statutory accounts as defined within the Companies Act 1985. 

The principal accounting policies applied in the preparation of the consolidated interim statements are those set out in the annual report and accounts for the year ended 30 June 2008.

The figures for the year ended 30 June 2008 are an abridged statement of the Group audited accounts for that year. The financial statements for the year ended 30 June 2008 were audited and have been delivered to the Registrar of Companies.

 

As is permitted by the AIM rules, the directors have not adopted the requirements of IAS34 'Interim Financial Reporting' in preparing the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.

2.

Income tax has been provided at the rate of 30.4% (2007 : 32.2%).

  

3.

Dividends

Half-year 

ended

31.12.08

£'000

Half-year 

ended

31.12.07

£'000

Year 

ended

30.06.08

£'000

Equity dividends paid :

Final dividend for the year ended 30 June 2007

-

5,751

5,751

Interim dividend for the year ended 30 June 2008

-

-

3,195

Final dividend for the year ended 30 June 2008

7,465

-

-

7,465

5,751

8,946

Equity dividends proposed at the end of the period

Interim dividend

3,732

3,195

-

Final dividend

-

-

7,465

Equity dividends per share, paid and proposed, are as follows :

 

11.25p final dividend for the year ended 30 June 2007, paid on 7 December 2007

6.25p interim dividend for the year ended 30 June 2008, paid on 23 May 2008

14.5p final dividend for the year ended 30 June 2008, paid on 12 December 2008

7.25p interim dividend for the year ended 30 June 2009, payable on 22 May 2009 to those shareholders on the register at the close of business on 22 April 2009.

  

4.

Calculation of earnings per ordinary share

Half-year 

ended

31.12.08

£'000

Half-year 

ended

31.12.07

£'000

Year 

ended

30.06.08

£'000

Basic earnings

10,700

8,871

20,355

Weighted average number of ordinary shares in issue

51,480,630

51,113,192

51,305,038

Weighted average number of ordinary shares in issue (diluted for the effect of outstanding share options)

51,624,129

51,558,120

51,519,840

Basic earnings per 5p ordinary share

20.8p

17.4p

39.7p

Diluted earnings per 5p ordinary share

20.7p

17.2p

39.5p

5.

Copies of the interim results

Copies of the interim results have been sent to shareholders. Further copies can be obtained from the company's registered office, Beechfield, Hollinhurst Road, Radcliffe, ManchesterM26 1JN.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SEAFWWSUSEDD
Date   Source Headline
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results
2nd Feb 20237:00 amRNSTrading Update
1st Dec 20224:36 pmRNSResults of Annual General Meeting
1st Dec 20227:00 amRNSChairman’s Statement to the Annual General Meeting
14th Oct 20225:46 pmRNSPosting of Annual R&A and Notice of AGM
3rd Oct 20227:00 amRNSPreliminary Results
14th Sep 20221:01 pmRNSNotice of Preliminary Results
16th Aug 20223:59 pmRNSPDMR Exercise of Share Options
10th Aug 20224:00 pmRNSPDMR Grant of Share Options
1st Aug 20227:00 amRNSTrading Update
13th Jul 202211:24 amRNSBlock Listing Six Monthly Return
5th May 202210:48 amRNSTR-1: Notification of Major Holdings
31st Mar 20227:00 amRNSInterim Results
1st Feb 20227:00 amRNSTrading Update
17th Jan 202211:00 amRNSTotal Voting Rights and Application for Listing
13th Jan 20222:50 pmRNSApplication for Bonus Shares
7th Jan 20229:36 amRNSBlock Listing Six Monthly Return
7th Jan 20229:32 amRNSTotal Voting Rights
18th Nov 202111:13 amRNSResults of Annual General Meeting
18th Nov 20217:00 amRNSChairman’s Statement to the Annual General Meeting
15th Oct 20214:00 pmRNSPosting of Annual R&A and Notice of AGM
4th Oct 20217:00 amRNSPreliminary Results
20th Sep 20212:46 pmRNSNotice of Preliminary Results
4th Aug 20217:00 amRNSTrading Update
14th Jul 20215:00 pmRNSBlock Listing Six Monthly Return
25th Jun 20214:35 pmRNSPrice Monitoring Extension
22nd Jun 20214:00 pmRNSPDMR Exercise of Share Options
31st Mar 20217:00 amRNSInterim Results
1st Feb 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSBlock Listing Six Monthly Return
12th Nov 202011:00 amRNSResults of Annual General Meeting
12th Nov 20207:00 amRNSChairman's Statement to the Annual General Meeting
16th Oct 20204:00 pmRNSPosting of Annual Report and Notice of AGM
1st Oct 20207:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.